Antithrombotics Pathophysiological Rationale for Pharmacological Interventions
| Other Authors: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Dordrecht
Springer Netherlands
1991, 1991
|
| Edition: | 1st ed. 1991 |
| Series: | Developments in Cardiovascular Medicine
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- 1. Platelet activation and aggregation: rationale for combining antithrombotic drugs
- 2. Role of nitric oxide in endothelial cell - platelet interactions
- 3. Platelets and megakaryocytes in vascular disease
- 4. Thrombosis in relation to atherosclerosis
- 5. Pharmacological inhibition of the ADP-GP IIb/IIIa-fibrinogen pathway of platelet aggregation
- 6. Calcium fluxes in platelets and endothelial cells, mechanisms and functional significance
- 7. Inhibition of platelet function by cyclic nucleotides and cyclic nucleotide-dependent protein kinases
- 8. Pharmacological modification of platelet-derived cyclooxygenase product formation and its consequences for platelet-vessel wall interactions
- 9. Antithrombotics and the lipoxygenase pathway
- 10. Pathological expressions of platelet-vessel wall interactions: implications of serotonin
- 11. The involvement of PAF in thrombotic events
- 12. Prostaglandins and -analogs in the treatment of platelet-vessel wall interaction
- 13. Adjuvant agents to enhance and sustain reperfusion with t-PA: studies in experimental dog models
- 14. Effect of dietary marine lipids on (anti-)thrombotic mechanisms